跳至主要内容
临床试验/NCT06109610
NCT06109610招募中不适用

A Randomized Control Trial of Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients on Follow up at Mattu Karl and Bedele Hospital, 2019

Mattu University2 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2021年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
128
试验地点
2
主要终点
The mean score of Depression will change after intervention

研究概览

简要总结

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy may solve these problem.

详细描述

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Poor adherence decreases the benefits of ART as well as chances of prolonged survival. An intervention that integrates CBT for depression with a cognitive behavioral approach to adherence counseling (cognitive behavioral therapy intervention for adherence and depression (CBT-AD)) has been found to be effective in improving adherence and reducing depression in PLWH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PLWHA who were 18 years old and above were included in the study

排除标准

  • PLWHA who were previously took CBT and participants with acute physical or mental disturbances were excluded.

结局指标

主要结局

The mean score of Depression will change after intervention

时间窗: Through study completion, an average of 1 yea

Depression is measured by Patient Health Questionnaire (PHQ-9) Depression Scale. The minimum value is 0 and the maximum value is 27. The higher score mean worse outcome

次要结局

未报告次要终点

研究者

发起方
Mattu University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zakir Abdu

Assistant Professor of Psychiatry

Mattu University

研究点 (2)

Loading locations...

相似试验